AstraZeneca, MRC Technology Partner With Charities on Lung Disease Research | GenomeWeb

NEW YORK (GenomeWeb) – British medical research charity MRC Technology announced today that it has partnered with Asthma UK, the British Lung Foundation, and AstraZeneca to study the link between epigenetics and respiratory disease, with the goal of discovering new treatments for asthma, chronic obstructive pulmonary disease, and other lung disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.